Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:L-FABP as a potential biomolecular marker of liver graft injury
Avtorji:ID Kalamutova, Ana (Avtor)
ID Plevel, Danaja (Avtor)
ID Djokić, Mihajlo (Avtor)
ID Jerin, Aleš (Avtor)
ID Trotovšek, Blaž (Avtor)
ID Petrič, Miha (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (964,76 KB)
MD5: B20281424F3216F72CE3C8CB938FA18A
 
URL URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2077-0383/14/20/7404
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Background: In recent years, indications for liver transplantation have expanded, while the age of transplant recipients has significantly increased due to improvements in perioperative management. As clinical manifestations of posttransplant complications vary and are often nonspecific, the identification of appropriate biomarkers is important for the assessment of graft quality and early recognition of potential complications following liver transplantation. Liver-type FABP (L-FABP) is a small cytoplasmic protein found abundantly in hepatocytes and is involved in the intracellular transport of long-chain fatty acids. Elevated serum levels have been detected in acute and chronic liver failure, kidney failure, and some malignancies. Materials and Methods: We conducted a prospective, single-center study from July 2023 to January 2025, including 29 adult patients who underwent deceased-donor transplantation. Three patients were excluded due to inadequate sample withdrawals. Serum L-FABP was measured preoperatively and on postoperative days 1, 3, 5, 7, and 14. Clinical, surgical, and biochemical data were collected and analyzed using non-parametric statistical tests. Results: L-FABP levels were significantly higher on POD 7 in recipients of grafts from donors ≥ 65 years (p = 0.035), with no corresponding changes in standard liver function markers. While no significant differences in L-FABP levels were found between patients with and without infectious biliary or vascular complications (all p > 0.05), we proved a strong negative correlation between intraoperative blood transfusion volume and L-FABP levels on POD 5 (ρ = −0.677, p < 0.001) and POD 7 (ρ = −0.455, p = 0.025). Conclusions: Our findings suggest that L-FABP holds promise as a biomarker for the early detection of subclinical hepatic graft cellular injury, which is not detected by means of conventional biomarkers for liver function.
Ključne besede:liver transplantation, biomarker, L-FABP, hepatic graft injury, marginal liver graft
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 1-16
Številčenje:Vol. 14, iss. 20, [article no.] 7404
PID:20.500.12556/DiRROS-24674 Novo okno
UDK:616.61
ISSN pri članku:2077-0383
DOI:10.3390/jcm14207404 Novo okno
COBISS.SI-ID:255639811 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 3. 11. 2025;
Datum objave v DiRROS:11.12.2025
Število ogledov:75
Število prenosov:33
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Journal of clinical medicine
Skrajšan naslov:J. clin. med.
Založnik:MDPI
ISSN:2077-0383
COBISS.SI-ID:5405759 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Univerzitetni klinični center Ljubljana
Številka projekta:20210075
Naslov:Napovedna vrednost FABP beljakovin kot označevalcev ishemične okvare jetrnega presadka ter zavrnitve jetrnega presadka pri bolnikih po presaditvi jeter.

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj